Form 8-K - Current report:
SEC Accession No. 0001437749-26-026790
Filing Date
2026-08-10
Accepted
2026-08-10 16:35:21
Documents
14
Period of Report
2026-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20260809_8k.htm   iXBRL 8-K 36463
2 EXHIBIT 99.1 ex_1001907.htm EX-99.1 282660
7 logo.jpg GRAPHIC 14431
  Complete submission text file 0001437749-26-026790.txt   490201

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dmac-20260810.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20260810_def.xml EX-101.DEF 11412
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20260810_lab.xml EX-101.LAB 15290
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20260810_pre.xml EX-101.PRE 11572
18 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20260809_8k_htm.xml XML 2842
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 261259012
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)